Product Code: TMRGL486
Heart Valve Devices Market - Scope of Report
TMR's report on the global heart valve devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global heart valve devices market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global heart valve devices market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the heart valve devices market.
Market Snapshot |
Market Value in 2023 | US$ 10.9 Bn |
Market Value in 2034 | US$ 38.2 Bn |
CAGR | 11.7% |
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global heart valve devices market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global heart valve devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global heart valve devices market.
The report delves into the competitive landscape of the global heart valve devices market. Key players operating in the global heart valve devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global heart valve devices market profiled in this report.
Key Questions Answered in Global heart valve devices Market Report:
- What is the sales/revenue generated by heart valve devices across all regions during the forecast period?
- What are the opportunities in the global heart valve devices market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2034?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Heart Valve Devices Market - Research Objectives and Research Approach
The comprehensive report on the global heart valve devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global heart valve devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global heart valve devices market.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Heart Valve Devices Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Segment Definition
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Heart Valve Devices Market Analysis and Forecasts, 2020-2034
- 4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
- 5.1. Insights on Global Burden of Cardiovascular Diseases
- 5.2. Regulatory Landscape for Heart Valve Devices in Key Regions / Countries
- 5.3. Overview on Cardiovascular Surgical Procedures
- 5.4. Key Industry Events (Product Approvals, Partnerships, and Collaborations)
- 5.5. Technological Advancements in the Field of Heart Valve Surgeries
- 5.6. Reimbursement Scenario across Key Regions / Countries
- 5.7. Pricing Trends of Heart Valve Devices
- 5.8. PEST Analysis
- 5.9. Key Product / Brand Analysis
- 5.10. Insights on Global Burden of Cardiovascular Diseases
6. Global Heart Valve Devices Market Analysis and Forecasts, By Type of Heart Valve
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast By Type of Heart Valve, 2020-2034
- 6.3.1. Aortic Valve
- 6.3.1.1. Less than 20 mm
- 6.3.1.2. 20-23 mm
- 6.3.1.3. 23-26 mm
- 6.3.1.4. More than 26 mm
- 6.3.2. Mitral Valve
- 6.3.2.1. Less than 26 mm
- 6.3.2.2. 26-28 mm
- 6.3.2.3. 29-31 mm
- 6.3.2.4. More than 31 mm
- 6.3.3. Tricuspid Valve
- 6.3.4. Pulmonary Valve
- 6.4. Market Attractiveness By Type of Heart Valve
7. Global Heart Valve Devices Market Analysis and Forecasts, By Material
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast By Material, 2020-2034
- 7.3.1. Biological Valves
- 7.3.1.1. TAVI
- 7.3.1.2. Surgical
- 7.3.1.3. Others
- 7.3.2. Mechanical Valves
- 7.4. Market Attractiveness By Material
8. Global Heart Valve Devices Market Analysis and Forecasts, By Age Group
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast By Age Group, 2020-2034
- 8.3.1. Pediatric Patients
- 8.3.2. Adults
- 8.3.3. Geriatric Patients
- 8.4. Market Attractiveness By Age Group
9. Global Heart Valve Devices Market Analysis and Forecasts, By End-user
- 9.1. Introduction & Definition
- 9.2. Key Findings / Developments
- 9.3. Market Value Forecast By End-user, 2020-2034
- 9.3.1. Hospitals
- 9.3.2. Ambulatory Surgical Centers
- 9.3.3. Others
- 9.4. Market Attractiveness By End-user
10. Global Heart Valve Devices Market Analysis and Forecasts, By Region
- 10.1. Key Findings
- 10.2. Market Value Forecast By Region
- 10.2.1. North America
- 10.2.2. Europe
- 10.2.3. Asia Pacific
- 10.2.4. Latin America
- 10.2.5. Middle East & Africa
- 10.3. Market Attractiveness By Region
11. North America Heart Valve Devices Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast By Type of Heart Valve, 2020-2034
- 11.2.1. Aortic Valve
- 11.2.1.1. Less than 20 mm
- 11.2.1.2. 20-23 mm
- 11.2.1.3. 23-26 mm
- 11.2.1.4. More than 26 mm
- 11.2.2. Mitral Valve
- 11.2.2.1. Less than 26 mm
- 11.2.2.2. 26-28 mm
- 11.2.2.3. 29-31 mm
- 11.2.2.4. More than 31 mm
- 11.2.3. Tricuspid Valve
- 11.2.4. Pulmonary Valve
- 11.3. Market Value Forecast By Material, 2020-2034
- 11.3.1. Biological Valves
- 11.3.1.1. TAVI
- 11.3.1.2. Surgical
- 11.3.1.3. Others
- 11.3.2. Mechanical Valves
- 11.4. Market Value Forecast By Age Group, 2020-2034
- 11.4.1. Pediatric Patients
- 11.4.2. Adults
- 11.4.3. Geriatric Patients
- 11.5. Market Value Forecast By End-user, 2020-2034
- 11.5.1. Hospitals
- 11.5.2. Ambulatory Surgical Centers
- 11.5.3. Others
- 11.6. Market Value Forecast By Country, 2020-2034
- 11.6.1. U.S.
- 11.6.2. Canada
- 11.7. Market Attractiveness Analysis
- 11.7.1. By Type of Heart Valve
- 11.7.2. By Material
- 11.7.3. By Age Group
- 11.7.4. By End-user
- 11.7.5. By Country
12. Europe Heart Valve Devices Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast By Type of Heart Valve, 2020-2034
- 12.2.1. Aortic Valve
- 12.2.1.1. Less than 20 mm
- 12.2.1.2. 20-23 mm
- 12.2.1.3. 23-26 mm
- 12.2.1.4. More than 26 mm
- 12.2.2. Mitral Valve
- 12.2.2.1. Less than 26 mm
- 12.2.2.2. 26-28 mm
- 12.2.2.3. 29-31 mm
- 12.2.2.4. More than 31 mm
- 12.2.3. Tricuspid Valve
- 12.2.4. Pulmonary Valve
- 12.3. Market Value Forecast By Material, 2020-2034
- 12.3.1. Biological Valves
- 12.3.1.1. TAVI
- 12.3.1.2. Surgical
- 12.3.1.3. Others
- 12.3.2. Mechanical Valves
- 12.4. Market Value Forecast By Age Group, 2020-2034
- 12.4.1. Pediatric Patients
- 12.4.2. Adults
- 12.4.3. Geriatric Patients
- 12.5. Market Value Forecast By End-user, 2020-2034
- 12.5.1. Hospitals
- 12.5.2. Ambulatory Surgical Centers
- 12.5.3. Others
- 12.6. Market Value Forecast By Country / Sub-region, 2020-2034
- 12.6.1. Germany
- 12.6.2. U.K.
- 12.6.3. France
- 12.6.4. Spain
- 12.6.5. Italy
- 12.6.6. Rest of Europe
- 12.7. Market Attractiveness Analysis
- 12.7.1. By Type of Heart Valve
- 12.7.2. By Material
- 12.7.3. By Age Group
- 12.7.4. By End-user
- 12.7.5. By Country / Sub-region
13. Asia Pacific Heart Valve Devices Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast By Type of Heart Valve, 2020-2034
- 13.2.1. Aortic Valve
- 13.2.1.1. Less than 20 mm
- 13.2.1.2. 20-23 mm
- 13.2.1.3. 23-26 mm
- 13.2.1.4. More than 26 mm
- 13.2.2. Mitral Valve
- 13.2.2.1. Less than 26 mm
- 13.2.2.2. 26-28 mm
- 13.2.2.3. 29-31 mm
- 13.2.2.4. More than 31 mm
- 13.2.3. Tricuspid Valve
- 13.2.4. Pulmonary Valve
- 13.3. Market Value Forecast By Material, 2020-2034
- 13.3.1. Biological Valves
- 13.3.1.1. TAVI
- 13.3.1.2. Surgical
- 13.3.1.3. Others
- 13.3.2. Mechanical Valves
- 13.4. Market Value Forecast By Age Group, 2020-2034
- 13.4.1. Pediatric Patients
- 13.4.2. Adults
- 13.4.3. Geriatric Patients
- 13.5. Market Value Forecast By End-user, 2020-2034
- 13.5.1. Hospitals
- 13.5.2. Ambulatory Surgical Centers
- 13.5.3. Others
- 13.6. Market Value Forecast By Country / Sub-region, 2020-2034
- 13.6.1. China
- 13.6.2. Japan
- 13.6.3. India
- 13.6.4. Australia & New Zealand
- 13.6.5. Rest of Asia Pacific
- 13.7. Market Attractiveness Analysis
- 13.7.1. By Type of Heart Valve
- 13.7.2. By Material
- 13.7.3. By Age Group
- 13.7.4. By End-user
- 13.7.5. By Country / Sub-region
14. Latin America Heart Valve Devices Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Market Value Forecast By Type of Heart Valve, 2020-2034
- 14.2.1. Aortic Valve
- 14.2.1.1. Less than 20 mm
- 14.2.1.2. 20-23 mm
- 14.2.1.3. 23-26 mm
- 14.2.1.4. More than 26 mm
- 14.2.2. Mitral Valve
- 14.2.2.1. Less than 26 mm
- 14.2.2.2. 26-28 mm
- 14.2.2.3. 29-31 mm
- 14.2.2.4. More than 31 mm
- 14.2.3. Tricuspid Valve
- 14.2.4. Pulmonary Valve
- 14.3. Market Value Forecast By Material, 2020-2034
- 14.3.1. Biological Valves
- 14.3.1.1. TAVI
- 14.3.1.2. Surgical
- 14.3.1.3. Others
- 14.3.2. Mechanical Valves
- 14.4. Market Value Forecast By Age Group, 2020-2034
- 14.4.1. Pediatric Patients
- 14.4.2. Adults
- 14.4.3. Geriatric Patients
- 14.5. Market Value Forecast By End-user, 2020-2034
- 14.5.1. Hospitals
- 14.5.2. Ambulatory Surgical Centers
- 14.5.3. Others
- 14.6. Market Value Forecast By Country / Sub-region, 2020-2034
- 14.6.1. Brazil
- 14.6.2. Mexico
- 14.6.3. Rest of Latin America
- 14.7. Market Attractiveness Analysis
- 14.7.1. By Type of Heart Valve
- 14.7.2. By Material
- 14.7.3. By Age Group
- 14.7.4. By End-user
- 14.7.5. By Country / Sub-region
15. Middle East & Africa Heart Valve Devices Market Analysis and Forecast
- 15.1. Introduction
- 15.2. Market Value Forecast By Type of Heart Valve, 2020-2034
- 15.2.1. Aortic Valve
- 15.2.1.1. Less than 20 mm
- 15.2.1.2. 20-23 mm
- 15.2.1.3. 23-26 mm
- 15.2.1.4. More than 26 mm
- 15.2.2. Mitral Valve
- 15.2.2.1. Less than 26 mm
- 15.2.2.2. 26-28 mm
- 15.2.2.3. 29-31 mm
- 15.2.2.4. More than 31 mm
- 15.2.3. Tricuspid Valve
- 15.2.4. Pulmonary Valve
- 15.3. Market Value Forecast By Material, 2020-2034
- 15.3.1. Biological Valves
- 15.3.1.1. TAVI
- 15.3.1.2. Surgical
- 15.3.1.3. Others
- 15.3.2. Mechanical Valves
- 15.4. Market Value Forecast By Age Group, 2020-2034
- 15.4.1. Pediatric Patients
- 15.4.2. Adults
- 15.4.3. Geriatric Patients
- 15.5. Market Value Forecast By End-user, 2020-2034
- 15.5.1. Hospitals
- 15.5.2. Ambulatory Surgical Centers
- 15.5.3. Others
- 15.6. Market Value Forecast By Country / Sub-region, 2020-2034
- 15.6.1. GCC Countries
- 15.6.2. South Africa
- 15.6.3. Rest of Middle East & Africa
- 15.7. Market Attractiveness Analysis
- 15.7.1. By Type of Heart Valve
- 15.7.2. By Material
- 15.7.3. By Age Group
- 15.7.4. By End-user
- 15.7.5. By Country / Sub-region
16. Competition Landscape
- 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
- 16.2. Company Profiles
- 16.2.1. Medtronic plc
- 16.2.1.1. Company Overview
- 16.2.1.2. Financial Overview
- 16.2.1.3. Product Portfolio
- 16.2.1.4. Business Strategies
- 16.2.1.5. Recent Developments
- 16.2.2. Boston Scientific Corporation
- 16.2.2.1. Company Overview
- 16.2.2.2. Financial Overview
- 16.2.2.3. Product Portfolio
- 16.2.2.4. Business Strategies
- 16.2.2.5. Recent Developments
- 16.2.3. Abbott
- 16.2.3.1. Company Overview
- 16.2.3.2. Financial Overview
- 16.2.3.3. Product Portfolio
- 16.2.3.4. Business Strategies
- 16.2.3.5. Recent Developments
- 16.2.4. Edwards Lifesciences Corporation
- 16.2.4.1. Company Overview
- 16.2.4.2. Financial Overview
- 16.2.4.3. Product Portfolio
- 16.2.4.4. Business Strategies
- 16.2.4.5. Recent Developments
- 16.2.5. Foldax Inc.
- 16.2.5.1. Company Overview
- 16.2.5.2. Financial Overview
- 16.2.5.3. Product Portfolio
- 16.2.5.4. Business Strategies
- 16.2.5.5. Recent Developments
- 16.2.6. Novostia SA
- 16.2.6.1. Company Overview
- 16.2.6.2. Financial Overview
- 16.2.6.3. Product Portfolio
- 16.2.6.4. Business Strategies
- 16.2.6.5. Recent Developments
- 16.2.7. Meril Life Sciences Pvt. Ltd.
- 16.2.7.1. Company Overview
- 16.2.7.2. Financial Overview
- 16.2.7.3. Product Portfolio
- 16.2.7.4. Business Strategies
- 16.2.7.5. Recent Developments
- 16.2.8. Corcym UK Limited
- 16.2.8.1. Company Overview
- 16.2.8.2. Financial Overview
- 16.2.8.3. Product Portfolio
- 16.2.8.4. Business Strategies
- 16.2.8.5. Recent Developments
- 16.2.9. JenaValve Technology, Inc.
- 16.2.9.1. Company Overview
- 16.2.9.2. Financial Overview
- 16.2.9.3. Product Portfolio
- 16.2.9.4. Business Strategies
- 16.2.9.5. Recent Developments
- 16.2.10. Micro Interventional Devices, Inc.
- 16.2.10.1. Company Overview
- 16.2.10.2. Financial Overview
- 16.2.10.3. Product Portfolio
- 16.2.10.4. Business Strategies
- 16.2.10.5. Recent Developments
- 16.2.11. Auto Tissue Berlin GmbH
- 16.2.11.1. Company Overview
- 16.2.11.2. Financial Overview
- 16.2.11.3. Product Portfolio
- 16.2.11.4. Business Strategies
- 16.2.11.5. Recent Developments
- 16.2.12. Anteris Technologies Ltd
- 16.2.12.1. Company Overview
- 16.2.12.2. Financial Overview
- 16.2.12.3. Product Portfolio
- 16.2.12.4. Business Strategies
- 16.2.12.5. Recent Developments
- 16.2.13. Thubrikar Aortic Valve, Inc.
- 16.2.13.1. Company Overview
- 16.2.13.2. Financial Overview
- 16.2.13.3. Product Portfolio
- 16.2.13.4. Business Strategies
- 16.2.13.5. Recent Developments
- 16.2.14. MicroPort Scientific Corporation
- 16.2.14.1. Company Overview
- 16.2.14.2. Financial Overview
- 16.2.14.3. Product Portfolio
- 16.2.14.4. Business Strategies
- 16.2.14.5. Recent Developments
- 16.2.15. Biosensors International Group, Ltd.
- 16.2.15.1. Company Overview
- 16.2.15.2. Financial Overview
- 16.2.15.3. Product Portfolio
- 16.2.15.4. Business Strategies
- 16.2.15.5. Recent Developments